Srinivas Vourganti to Androgen Antagonists
This is a "connection" page, showing publications Srinivas Vourganti has written about Androgen Antagonists.
Connection Strength
0.196
-
Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. Eur Urol. 2021 09; 80(3):386.
Score: 0.196
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.